162 related articles for article (PubMed ID: 38364700)
1. Clinical implementation of preemptive pharmacogenomics in psychiatry.
Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
[TBL] [Abstract][Full Text] [Related]
2. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.
Fragoulakis V; Roncato R; Bignucolo A; Patrinos GP; Toffoli G; Cecchin E; Mitropoulou C
Pharmacol Res; 2023 Nov; 197():106949. PubMed ID: 37802427
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study.
Koufaki MI; Fragoulakis V; Díaz-Villamarín X; Karamperis K; Vozikis A; Swen JJ; Dávila-Fajardo CL; Vasileiou KZ; Patrinos GP; Mitropoulou C
Hum Genomics; 2023 Jun; 17(1):51. PubMed ID: 37287029
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.
Stäuble CK; Lampert ML; Allemann S; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE; Imboden C; Mikoteit T
Trials; 2021 Dec; 22(1):919. PubMed ID: 34906208
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.
Mitropoulou C; Fragoulakis V; Bozina N; Vozikis A; Supe S; Bozina T; Poljakovic Z; van Schaik RH; Patrinos GP
Pharmacogenomics; 2015 Jan; 16(2):137-48. PubMed ID: 25616100
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
[TBL] [Abstract][Full Text] [Related]
9. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
[No Abstract] [Full Text] [Related]
10. Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
Reizine N; Vokes EE; Liu P; Truong TM; Nanda R; Fleming GF; Catenacci DVT; Pearson AT; Parsad S; Danahey K; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
Ther Adv Med Oncol; 2020; 12():1758835920974118. PubMed ID: 33414846
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention.
Fragoulakis V; Bartsakoulia M; Díaz-Villamarín X; Chalikiopoulou K; Kehagia K; Ramos JGS; Martínez-González LJ; Gkotsi M; Katrali E; Skoufas E; Vozikis A; John A; Ali BR; Wordsworth S; Dávila-Fajardo CL; Katsila T; Patrinos GP; Mitropoulou C
Pharmacogenomics J; 2019 Oct; 19(5):438-445. PubMed ID: 30647444
[TBL] [Abstract][Full Text] [Related]
13. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
[TBL] [Abstract][Full Text] [Related]
14. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VH; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; Swen JJ; Guchelaar HJ;
Clin Pharmacol Ther; 2017 Mar; 101(3):341-358. PubMed ID: 28027596
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model.
van der Wouden CH; Marck H; Guchelaar HJ; Swen JJ; van den Hout WB
Front Pharmacol; 2022; 13():918493. PubMed ID: 36120299
[No Abstract] [Full Text] [Related]
16. Pre-emptive pharmacogenomics implementation among polypharmacy patients 65 years old and older: a clinical pilot.
Uber R; Hayduk VA; Pradhan A; Ward T; Flango A; Graham J; Wright EA
Pharmacogenomics; 2023 Dec; 24(18):915-920. PubMed ID: 37965783
[No Abstract] [Full Text] [Related]
17. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
Kim K; Magness JW; Nelson R; Baron V; Brixner DI
J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
[TBL] [Abstract][Full Text] [Related]
18. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Pérez V; Salavert A; Espadaler J; Tuson M; Saiz-Ruiz J; Sáez-Navarro C; Bobes J; Baca-García E; Vieta E; Olivares JM; Rodriguez-Jimenez R; Villagrán JM; Gascón J; Cañete-Crespillo J; Solé M; Saiz PA; Ibáñez Á; de Diego-Adeliño J; ; Menchón JM
BMC Psychiatry; 2017 Jul; 17(1):250. PubMed ID: 28705252
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]